CLINICAL_TRIALS
trial_result
· 2025-10-30
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD) [Phase 3]
Summary
Phase 3 study evaluating pegcetacoplan for cold agglutinin disease has completed, with trial results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Swedish Orphan Biovitrum | Conditions: Cold Agglutinin Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-10-30